The High Authority for Health (HAS) gives the green light to three anti-Covid-19 vaccines adapted to Omicron for a new booster vaccination campaign planned for the fall and coupled with that against the flu, it announced Tuesday, September 20 in a press release.
Read alsoCovid-19: why the long-awaited nasal vaccine is still not ready
This new booster dose will be recommended to people at risk of a severe form, to those around them and to caregivers.
The HAS recommends "
indifferently one of the three bivalent vaccines
" - two developed by Pfizer / BioNTech, the third by Moderna - recently validated by the European Medicines Agency.
